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Background: Gene name recognition and normalization is, together with detection of other named enti-
ties, a crucial step in biomedical text mining and the underlying basis for development of more advanced
techniques like extraction of complex events. While the current state of the art solutions achieve highly
promising results on average, performance can drop signiﬁcantly for speciﬁc genes with highly ambigu-
ous synonyms. Depending on the topic of interest, this can cause the need for extensive manual curation
of such text mining results. Our goal was to enhance this curation step based on tools widely used in
pharmaceutical industry utilizing the text processing and classiﬁcation capabilities of the Konstanz Infor-
mation Miner (KNIME) along with publicly available sources.
Results: F-score achieved on gene speciﬁc test corpora for highly ambiguous genes could be improved
from values close to zero, due to very low precision, to values >0.9 for several cases. Interestingly the pre-
sented approach even resulted in an increased F-score for genes showing already good results in initial
gene name normalization. For most test cases, we could signiﬁcantly improve precision, while retaining
a high recall.
Conclusions: We could show that KNIME can be used to assist in manual curation of text mining results
containing high numbers of false positive hits. Our results also indicate that it could be beneﬁcial for
future development in the ﬁeld of gene name normalization to create gene speciﬁc training corpora based
on incorrectly identiﬁed genes common to current state of the art algorithms.
 2014 Elsevier Inc. All rights reserved.1. Introduction
1.1. Background
Gene mention detection and subsequent normalization is a cru-
cial step in text mining applications within the biomedical and
pharmaceutical domain. Together with detection of other named
entities it is the driver of more recent tasks in natural language
processing like event extraction [1,2]. The performance of gene
normalization is usually measured by the F-score reached on the
document set developed for the BioCreative II gene normalization
task [3]. Geno by Wermter et al. [4] and GNAT by Hakenberg
et al. [5] are probably the best approaches currently available
and reach an F-score of about 86% on the BioCreative II corpus.Recently, Li et al. even reported experimental results showing an
F-score > 90% on this data set [6]. From a practical perspective,
two additional aspects have to be considered. First of all, those val-
ues present an average between genes, for which the approach
works extraordinarily well, and genes where precision and recall
are way below those numbers. Secondly, even an F-score of 86%
might result in a potentially high number of information that is
missed vs. a still signiﬁcant number of false positive hits that has
to be curated manually. Apart from gene names that also stand
for other biomedical entities like diseases or cell lines, the problem
is mainly caused by ambiguous abbreviations. For example the
synonym ‘‘SAH’’ for gene id 6296, might not appear as a problem
in a very broad context. However, in the context of ‘‘hemorrhage’’
a huge number of false positive hits for SAH – being the abbrevia-
tion of ‘‘subarachnoid hemorrhage’’ – might hide more relevant
results. Such problems will not be detected, when testing against
a set like BioCreative II, as the problematic gene might be men-
tioned with a low frequency or not at all, as in the case of SAH.
The aim of this study was to propose a method for ﬁltering these
typical false positive hits, based on tools widely used in
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tion and gene name normalization in scientiﬁc literature still rely
on articles that are listed in PubMed [7]. Therefore, a lot of manu-
ally curated information is publicly available. This still holds true
to a certain extent when full text articles are investigated. Many
articles can be mapped to their citation in PubMed and thus again
to the manual annotation, e.g. via the digital object identiﬁer (DOI)
[8] using tools like the National Center for Biotechnology Informa-
tion (NCBI) ID converter [9]. A direct use of available human-
curated information is not feasible for the aforementioned gene
name normalization algorithms that should be applicable to any
kind of text. However, as our approach is designed to solve a prac-
tical problem based on PubMed listed articles, this manual annota-
tions are indeed a valuable source of information. As described
above, the problem usually comprises a large number of abstracts
containing the same ambiguous synonym of a single gene. Datasets
like BioCreative II are not suitable to simulate that situation. We
therefore manually created training and test data sets meeting this
requirement. We chose the Konstanz Information Miner (KNIME)
[10] as the underlying platform for implementation as it is freely
available but is also used within the pharmaceutical industry.
Thus, it allows for easy integration of our workﬂow in existing data
analysis pipelines. It provides a graphical interface where tabular
data is handled via a series of interconnected ‘‘nodes’’ that wrap
functions to process the incoming data. These nodes are organized
within workﬂows, i.e. sets of connected nodes usually starting with
a node for data retrieval or reading, followed by data processing
nodes and completed by output or visualization nodes in the
end. KNIME is already widespread mainly within chemistry for
dealing with large datasets and several extensions for various
chemical tasks have been developed over time. Only very recently
an extension for text processing has been added [11] and enables
KNIME to be used in natural language processing tasks. We also
focused in this study on using publicly available resources wher-
ever possible. Similar to the approach by Wermter et al. [4] it
was our intention to minimize the necessary manual effort to
curate any kind of dictionaries. We developed a workﬂow consist-
ing of two major steps incorporating and extending some concepts
introduced earlier in gene normalization algorithms [12]. Step 1
aims at the identiﬁcation of unambiguously true positive or clearly
false positive hits by rather strict string matching to dictionaries,
resolution of abbreviations and identiﬁcation of existing manual
annotation in the public domain. In step 2, a support vector
machine classiﬁer for a speciﬁc gene is trained with the two sets
created in step 1 in order to classify the remaining hits. In contrast
to other approaches, we also use the context of gene speciﬁc false
positives in addition to simple ﬁltering of results containing black-
listed terms.
1.2. Related work
Gene name normalization usually comprises several steps: Rec-
ognition of possible gene mentions, generation of candidate pairs
for normalization and disambiguation, i.e. choosing the correct
normalized form. Additionally, most algorithms include a ﬁltering
step to remove the aforementioned false positive hits. Li et al. [6]
use a Wikipedia based ﬁlter to remove mentions of gene families,
which were considered false positives in gene normalization tasks,
as it is not possible to assign a unique identiﬁer. Wermter et al. [4]
employed a similar approach, but enriched the Wikipedia derived
blacklist with several MeSH (Medical Subject Heading) [13] terms
and protein family as well as complex annotations taken from the
GENIA corpus [14]. These ﬁlter steps, however, were mostly intro-
duced to meet the requirements of the task for comparability, but
exclusion of hits for protein families does not remove the more
problematic false positive hits described above. Hu et al. [12] takethe Wikipedia based ﬁlter only as an addition to a machine learn-
ing approach, generating a conﬁdence score for each gene mention.
They combine this method with a ﬁnal quality assessment via
cosine similarity of context vectors. In contrast to those
approaches, GNAT by Hakenberg et al. [5,15] introduces ﬁltering
already before the disambiguation step. Their algorithm includes
resolution of ambiguous abbreviations in a training data set, both
locally and on abstract level, to calculate likelihoods of hits being
false positive dependent on their local context. They additionally
also employ blacklists for unspeciﬁc gene names. Other than pro-
tein families, the lists also include amino acids, diseases, tissues
and species. Finally, GNAT contains a heuristic approach, to accept
gene synonyms that are common English words or biomedical
terms only when an additional unambiguous synonym is present.
A common scheme among these ﬁlter steps is that false positive
hits are simply discarded and the information contained within
their context is not used in a gene speciﬁc way. In addition to these
existing false positive ﬁlters, we propose to include a classiﬁcation
step that explicitly uses the context of typical false positives for a
speciﬁc gene.2. Methods
2.1. Workﬂow overview
The ﬁrst step in our workﬂow was re-introduction of already
available manual annotations linking articles to gene information,
as provided by the NCBI and the Universal Protein Resource (Uni-
Prot) [16]. We also made use of the corresponding MeSH (Medical
Subject Heading) annotation corresponding to the gene of interest.
While those sources are far from complete, they should comprise a
reliable dataset for identiﬁcation of correct gene mentions. This
part of the curation workﬂow, as shown in Fig. 1 also included
slightly fuzzy dictionary matching of correct gene names via a
Lucene index [17] in order to identify articles clearly mentioning
the candidate gene. On the other hand, we identiﬁed false positive
hits at that point via blacklists and acronym expansion.
After these steps, the initial text mining result set had been split
into three parts: Set 1 comprises a set of abstracts where the gene
was identiﬁed correctly (assuming that manual curation in the
employed databases was correct) and set 2 should contain only
clearly false positive hits. For set 3, however, no decision had been
made yet. Therefore the second round of disambiguation makes
use of built-in functionalities of KNIME and several publicly avail-
able extensions. Context vectors were created from the abstracts in
set 1 and 2 to train a gene speciﬁc support vector machine (SVM)
classiﬁer. This classiﬁer was used to create datasets 3.1 and 3.2,
as shown in the diagram in Fig. 1 comprising ‘‘probably true posi-
tive’’ or ‘‘probably false positive hits’’, respectively.
2.2. Identiﬁcation of possible gene mentions in PubMed abstracts
Linguamatics I2E version 4.1 [18] was used to initially detect
possible mentions of a gene of interest within PubMed abstracts.
I2E allows for setting a threshold for disambiguation. This thresh-
old was set to the lowest possible value for this initial step in order
to increase recall to a maximum. We intentionally ignored the
reduced precision and thus a high number of false positive hits
had been included.
2.3. Gene dictionary
The gene dictionary used at several points in the curation work-
ﬂow was derived from the synonyms of the human, mouse and rat
gene variants as included in the NCBI gene database [19]. These
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Fig. 1. Schematic overview of the automated curation workﬂow.
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name from nomenclature authority’’ and ‘‘other designation’’ in
the ‘‘gene_info’’ ﬁle. No further modiﬁcations to the terms had been
made, apart from exclusion of synonyms that are abbreviations on
its own, like the synonym SAH, for the genewith the identiﬁer 6296.
2.4. Identiﬁcation of existing manual annotations in PubMed
Two obviously helpful resources for PubMed abstracts are the
MeSH annotations and the gene2pubmed mapping available at
the NCBI [20]. We additionally used the manually created mapping
between proteins, gene symbols and corresponding PubMed iden-
tiﬁers (PMIDs) contained within the UniProt database [16]. The
PMIDs of gene mention containing articles were identiﬁed and
mapped to those lists. Moreover, the articles contained in these
lists were used to identify the most frequent MeSH terms associ-
ated with literature about the gene of interest. From this subset
terms sharing some string similarity (scaled Levenshtein dis-
tance > 0.9) with the synonyms in the gene dictionary were chosen.
Otherwise very general and widely used MeSH terms like e.g.
‘‘Human’’ tend to be ranked highest. For genes sharing the same
abbreviation for their ofﬁcial gene symbol and the corresponding
protein entry on Uniprot, the MeSH Supplementary Concept ‘‘Gene-
Symbol protein, human’’ was also considered to be a correct manual
annotation, as it is likely that an unambiguous connection between
this gene and only one protein can be assumed. The subset of
abstracts containing correctly identiﬁed genes was enriched with
abstracts containing these MeSH annotations.
An additional mapping of PMIDs to the gene2pubmed entries
for bacterial and viral genes was used in order to move those arti-
cles into the false positive set. Especially highly ambiguous syn-
onyms like p40 or gp55 that already refer to several different
human genes, additionally also refer to viral and bacterial genes.
Thus this step helps to reduce false positives without the risk of
losing a correctly identiﬁed human gene.
2.5. Acronym expansion
Acronyms were expanded in several steps. In a ﬁrst step, the
text is searched for known meanings of the detected acronym. This
blacklist was compiled from several public domain sources. These
include Allie [21,22], a database developed by Integrated DatabaseProject, MEXT, Japan and a list compiled using the AcroTagger algo-
rithm [23] on MEDLINE abstracts.
To expand additional acronyms, regular expressions were gen-
erated at runtime to resolve patterns like e.g. abbreviations fol-
lowed by brackets or abbreviations in brackets. For the former
case, the text within brackets was considered to be the meaning
of the acronym when all letters of the acronym were contained
(numbers, articles and short prepositions were ignored). Several
possible alternatives were considered for the latter case. Simple
matching between the starting letters of words preceding or fol-
lowing the brackets and the acronym letters was employed ﬁrst.
Matching hits were assumed to be correct interpretations of the
acronym. This step also allowed for matches containing a lower
number of words than inferred by the abbreviation similar to the
search for head patterns in the BADREX approach [24]. If the regu-
lar expression did not match, the last word preceding or the ﬁrst
word following the bracket was examined and considered correct
if the letters of the acronym had been found in the correct order.
This helped to resolve acronyms like MAX, that usually stands for
words like ‘‘maximum’’ or ClU for ‘‘5-chlorouracil’’.
We also used the gene dictionary described above to identify
articles where the correct long form of a gene abbreviation was
mentioned. Indexing was performed via the KNIME Table Indexer
node which allows for searching using a Lucene based query syn-
tax [17]. A slightly fuzzy Lucene query had been employed (Lucene
query: GeneSynonym0.95). This still allowed for matching small
writing differences in rather long synonyms. For example, ‘‘dehy-
dro-epiandrosterone preferring’’ or a misspelling like ‘‘dehydorepi-
androsterone preferring’’ would still be accepted when
‘‘dehydroepiandrosterone preferring’’ was the query phrase. How-
ever, for shorter synonyms only exact matches were accepted. If a
correct hit for the gene had been found, a previously identiﬁed
blacklist entry was ignored. This is especially important for those
genes whose synonymous abbreviations were derived from related
disorders. In those cases, ambiguous and unambiguous synonyms
of a gene can be found within in the abstract, with different mean-
ings. For acronyms resolved via a regular expression, the identiﬁed
expanded form was additionally cross-checked for string similarity
with gene dictionary entries and not considered a false positive hit
if this similarity was high, deﬁned by a scaled Levenshtein dis-
tance > 0.5 [25] and the abstract was included in the ‘‘unclassiﬁed’’
subset 3 for further classiﬁcation.
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Another practically oriented addition to the workﬂow is the
reduction of conﬁdence values, calculated by the subsequent clas-
siﬁcation step described below, for articles mentioning plant
related MeSH terms (like e.g. Arabidopsis). A positive classiﬁcation
bias is instead calculated for articles mentioning the ofﬁcial human
gene symbol within a comma separated list of potential gene sym-
bols. This kind of lists is often found in gene expression studies. For
these publications, however, both our ﬁlter steps would fail. In
most cases there is neither MeSH annotation for all genes with
altered expression nor an expanded form of the gene symbol con-
tained in the abstract. The context based classiﬁcation will also fail,
as the context is not gene speciﬁc.
These lists were identiﬁed by the regular expression
/([A-Z0-9-nsn(n)(orf)(rs)]+ns⁄,ns⁄){2,}[A-Z0-9-nsn(n)(orf)(rs)]+ns⁄,
?ns⁄(and [A-Z0-9-nsn(n)(orf)(rs)]+)?/
The expression for a single list item [A-Z0-9-nsn(n)(orf)(rs)]+
takes into account that most human gene symbols contain only
uppercase letters, numbers and hyphens. Thus one or more of these
characters (indicated by the ‘‘ + ’’ after the square brackets) is
required. It also allows for whitespaces (ns) and brackets within
the symbol. A typical example of such lists can be found in the article
with PMID: 21152965 (‘‘PICALM, CR1, CLU, PCK1, and ZNF224’’).
These lists also tend to contain genomic locations (so called ‘‘open
reading frames’’) which are typically notated using upper case let-
ters, numbers and the sequence ‘‘orf’’, e.g. ‘‘TDP2, ACOT13,
C6orf62, FAM65B, and CMAHP’’ in PMID: 24509779.We furthermore
included the sequence ‘‘rs’’ in our regular expression to identify lists
containing single nucleotide polymorphisms (SNPs) whose nomen-
clature usually follows the standard ‘‘rs’’ (for ‘‘reference SNP’’) fol-
lowed by a sequence of digits (e.g. PMID: 24042540: rs1464510-
LPP, rs1881457-IL13, rs2104286-IL2RA). The overall expression
matches lists containing two or more items ({2,}) followed by a
comma and optional whitespaces (ns⁄,ns⁄) and another item only
optionally followed by a comma or whitespaces (ns⁄,? ns⁄). The last
part of the regular expression contains the string ‘‘and’’ to allow
for the typical ending of comma separated lists in English language,
distinguishing the last bullet point by an ‘‘and’’ as seen in the ﬁrst
two examples. This entire group (indicated by the braces) is optional
in order tomatch listswithout this ending, like in the third example.
After detection of the list, the ofﬁcial gene symbol was searched
within the identiﬁed section, allowing only for hyphens or white-
spaces between letters and numbers (e.g. MOXD1, MOXD 1 and
MOXD-1).
2.7. Context vector creation and classiﬁcation
All abstracts were processed via the KNIME text processing
nodes. The sub-workﬂow comprised the standard nodes contained
within in this package for part-of-speech tagging, bag-of-word cre-
ation, punctuation removal and the built-in list for English stop
word ﬁltering. We additionally ﬁltered out words shorter than 3
characters and applied the Porter stemming algorithm [26]. How-
ever, no dedicated biomedical named entity recognition step was
included. Up to 10 keywords per abstract were subsequently deter-
mined using the KeyGraph [27] implementation included in the
KNIME text processing package. Vectors were created using the
most abundant keywords in set 1 and 2 and acronyms that had
been recognized as possible gene mentions were excluded. This
was important in order to classify depending on the context of
ambiguous acronyms only. For classiﬁcation of set 3, a support
vector machine classiﬁer was trained employing the vectors
created from set 1 and 2. We made use of the Weka integration
for KNIME and the model was trained utilizing the libsvm [28]implementation within this package, and in particular utilizing
the AdaBoostM1 node which additionally wraps classiﬁer training
in a boosting algorithm [29]. We chose the nu-SVM algorithm [30]
from the various options available in libsvm, and thus, classiﬁca-
tion is not possible if set 1 or 2 are empty. However, this is likely
to happen for rather small datasets, e.g. for genes that have not
been deeply investigated, yet. Although our approach was mainly
aimed at datasets that are relatively large due to a high number
of false positive hits, we implemented fallback solutions for these
harder to classify small sets. As a ﬁrst fallback option the one-class
SVM algorithm [30] was used, when at least one of the two sets
was populated. This algorithm allows for SVM classiﬁcation if only
one class is available. In this case the algorithm needs to choose
whether a hit belongs to this class or not in contrast to other ver-
sions that are used to choose between various classes. If this clas-
siﬁcation failed as well, we did at least a simple search for the
ofﬁcial gene symbol with the modiﬁcations described above for
identiﬁcation in lists in Section 2.6. This is a plausible fallback
option from a practical point of view, as we are probably looking
at rather unknown genes in that case. Therefore, researchers might
have found them incidentally (e.g. in expression analyses) and thus
use the ofﬁcial gene name, and not a trivial name established in
their lab or community. The latter matching step for ofﬁcial gene
symbols was also used in cases where all abstracts were classiﬁed
as false positive hits, assuming that this is rather unlikely in a lar-
ger dataset and thus this step might help to increase recall.
2.8. Training and test corpus creation
Publicly available corpora were not suitable to simulate the
problem of removing a huge number of false positives for a single
gene. We therefore created a training and test corpus using Lingua-
matics I2E to retrieve PubMed abstracts mentioning any synonym
of one single gene, ignoring any calculated conﬁdence whether a
synonym might indeed stand for a gene. The synonyms included
all abbreviations for a speciﬁc gene contained in the NCBI gene
database and all long forms of the gene and protein names listed
there with some modiﬁcations introduced by I2E. This procedure
was chosen to make sure that false positive hits were included in
the datasets. The genes were chosen from real-world examples
where those genes appeared as problematic. We veriﬁed that these
genes were underrepresented in the BioCreative II dataset. In the
manual curation step, a gene was accepted as long as a human,
mouse or rat variant of the gene was mentioned.
The training dataset comprised the following genes:
 gene id 1075 (ambiguous synonyms: PLS, HMS, PALS, JP, JPD,
6132 abstracts);
 gene id 84867 (STEP, 460 abstracts);
 gene id 4149 (MAX, 1202 abstracts).
The test dataset comprised the following genes:
 gene id 1191 (CLU,CLI, 3965 abstracts);
 gene id 6296 (SAH,SA, 923 abstracts);
 gene id 26002 (MOX, 391 abstracts);
 gene id 6822 (DHEAS, STD, 1008 abstracts);
 gene id 6742 (SSBP,198 abstracts).
In order to obtain additional information about the overall per-
formance of the two ﬁlter steps, we created a set of PubMed
abstracts, for 862 random genes from real-world examples, con-
taining at least 200 abstracts per gene. This set was created as
described above but not curated manually and only used to inves-
tigate the average proportion of abstracts in set 1, 2 and 3 after the
ﬁrst ﬁlter step.
62 M. Zwick / Journal of Biomedical Informatics 53 (2015) 58–643. Results and discussion
3.1. Experimental setup
The individual steps of the curation workﬂow were chosen and
thresholds for fuzzy string matching and SVM classiﬁcation were
tuned using the highly ambiguous genes in the training dataset
described in Section 2.8. F-scores were calculated according to
Eq. (1).
F ¼ 2 precision  recall
precisionþ recall ð1Þ
Precision and recall in Eq. (1) were deﬁned as shown in Eqs. (2)
and (3):
precision ¼ true positives
true positivesþ false positives ð2Þ
recall ¼ true positives
true positivesþ false negatives ð3Þ
For testing, we picked several examples of genes that occurred
in text mining results focused around mapping of genes to diverse
topics. Those genes were characterized by resulting in rather high
numbers of false positive hits compared to correct hits in these
result sets. Due to this setup, the calculated F-scores are gene spe-
ciﬁc and cannot be directly compared to F-scores calculated for
example in the BioCreative shared tasks. In order to investigate
possible improvements achievable with our workﬂow, we calcu-
lated precision, recall and F-score with several different settings
in I2E, either optimized for one parameter (precision or recall)
and a speciﬁc gene or a value working equally well for different
genes. For the three training data sets our KNIME based approach
achieved F-scores of 0.96 (gene id: 1075), 0.94 (gene id: 84867)
and 0.92 (gene id: 4149).
3.2. Test set results
The results for precision, recall and overall performance on the
test data sets are summarized in Table 1.
The strength of the automated curation approach can be seen
especially in cases where the initial gene name normalization fails
largely. We tested the approach on the gene with identiﬁer 6296.Table 1
Comparison of initial gene normalization and automated curation results.
Gene id, synonyms Precision Recall F-score
Standard 26002, MOX 0.03 1.00 0.06
Optimized precision 26002, MOX 0.08 0.82 0.15
KNIME 26002, MOX 0.91 0.91 0.91
Standard 6296, SAH, SA 0 1 0
Optimized precision 6296, SAH, SA 0 1 0
KNIME 6296, SAH, SA 1 1 1
Standard 1191, CLU, CLI 0.99 0.92 0.95
Optimized precision 1191, CLU, CLI 0.99 0.69 0.81
Optimized recall 1191, CLU,CLI 0.89 0.98 0.94
KNIME 1191, CLU, CLI 0.96 0.99 0.98
Standard 6742, SSBP 0.72 0.89 0.80
Optimized precision 6742, SSBP 0.90 0.61 0.72
Optimized recall 6742, SSBP 0.55 0.98 0.71
KNIME 6742, SSBP 0.80 0.99 0.88
Standard 6822, DHEAS, STD 0.18 0.92 0.30
Optimized precision 6822, DHEAS, STD 0.40 0.62 0.49
KNIME 6822, DHEAS, STD 1 0.59 0.74
Comparison of achievable performance by the initial gene name recognition and
normalization implemented in Linguamatics I2E alone to results of the KNIME
curation workﬂow (highlighted in bold font). I2E results were generated with
various disambiguation thresholds, either optimized for recall, precision or overall
performance on different genes. For genes 6822, 6296 and 26002 the optimal recall
was reached with the standard setting.Unfortunately, this gene is named SAH in older publications, and
the synonym should thus not be excluded generally. However
more recent publications do not use this synonym anymore. Limit-
ing our search to publications from the years 2011 and 2012, we
found 1258 potential occurrences of the gene. However, 1257
times SAH was mentioned, referring to something like the disor-
ders ‘‘subarachnoid hemorrhage’’, ’’severe alcoholic hepatitis’’ or
the substance ‘‘S-adenosyl-homocysteine’’. Even when setting the
threshold in I2E to optimized precision, we ended up with 303 hits,
at least including the one correct mention. With the standard set-
ting, the correct hit was even hidden in 975 hits. These false posi-
tive hits are often created by sections like ‘‘SAH stimulates tyrosine
kinase pathway to increase intracellular Ca2+’’ in the abstract with
PMID:9886354 or ‘‘SAH inhibits isoprenylcysteine carboxyl methyl-
transferase’’ in the fulltext article with PubMed Central ID 1395315
where it would be even for a human curator almost impossible to
tell, whether SAH refers to a gene/protein in these sections or not.
After automated curation, however, only the correct hit was left.
Another example was the gene with identiﬁer 26002, where most
false positive hits are caused by the synonym MOX, also referring
to the antibiotic moxiﬂoxacin. In this case, we could improve from
an F-score of 0.15 up to a value of 0.91.
Interestingly, the automated curation could also improve over-
all performance in cases where initial quality was already compa-
rably good or at least average. For the gene 1191 (CLU, CLI) we
could increase the F-score from 0.95 to 0.98 and for gene 6742
(SSBP) from 0.80 to 0.88. It should be noted that for both genes pre-
cision was signiﬁcantly higher after automated curation, when
compared to the I2E results alone tuned to a comparable recall
(Table 1).
3.3. Overall Performance of individual steps
After the ﬁrst ﬁlter step (i.e. acronym expansion, mapping of
manual annotations and string matching of correct synonyms
and blacklists) we observed an average proportion of 31% (median)
of abstracts in set 3, i.e. unclassiﬁed. An important ﬁnding was, that
for 418 out of the 862 genes in this set, the number of abstracts in
set 1 or 2 was clearly biased into one direction (>10-fold). The sub-
sequent classiﬁcation might thus tend to favor the over-repre-
sented class. This behavior should be beneﬁcial, as e.g. a low
number of false positive hits in the ﬁrst step, might indicated that
the gene is rather unproblematic and most mentions are probably
true.
The SVM classiﬁcation step alone achieved an average F-score of
0.64 with a precision of 0.58 and a recall of 0.72 on subset 3 for the
9 genes investigated in this publication. It has to be noted, that
‘‘easy’’ to classify gene mentions had been already tackled by the
ﬁrst ﬁlter step, and the classiﬁer only deals with the remaining
harder to identify examples.
3.4. Limitations
The ﬁrst step of our approach relies partially on the availability
of manually curated data. Therefore, e.g. a low number of entries in
the gene2pubmed ﬁle for a speciﬁc gene could be potentially prob-
lematic when a large number of mentions is detected for this gene.
We created a subset from the large 862 gene dataset, containing
only genes characterized by a relatively low number of gene2pub-
med entries, while a potential gene mention was detected in a
large number of abstracts (P100 ⁄ number of gene2pubmed
entries). We found 48 genes in our dataset fulﬁlling these criteria.
Interestingly, this seems to be a good indicator of genes, with a
highly ambiguous synonymous abbreviation. Thus, a much higher
number of hits had been sorted out by the acronym resolution step,
shown by a clearly increased average size of set 2 (false positives)
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of manually curated data can be compensated by the other steps in
many cases.
For gene identiﬁer 6822, we found a clear limitation of the
approach, as we did not reach better results than the original gene
name normalization in terms of recall. This was due to the fact that
the classiﬁcation step failed for most abstracts, as the major false
positive hit DHEAS, used as abbreviation for the hormone dehydro-
epiandrosterone, was also found in abstracts mentioning other
synonyms of the gene, as the encoded protein (sulfotransferase)
is indeed processing this compound [31]. Nevertheless, when tun-
ing the initial gene recognition step to maximum precision, we still
reach better precision (1 vs. 0.4), while hardly sacriﬁcing recall
(0.59 vs. 0.62, or 22 correct hits vs. 23), resulting in an F-score of
0.75 (vs.0.49) after automated curation (Table 1). Therefore our
goal of reducing false positive hits without reducing recall was
almost reached even in that case.
The slightly fuzzy string matching in identiﬁcation of the possi-
ble expanded forms of gene acronyms results in an additional
intrinsic limitation: The automated curation approach does not
improve the performance of the initial gene name normalization
with regard to several members of a protein family, e.g. ‘‘estrogen
receptor 1’’ would not be additionally distinguished from ‘‘estro-
gen receptor 2’’ if initial disambiguation had failed. The algorithm
would assume both suggested options are a true positive hit, as
long as ‘‘estrogen receptor’’ is mentioned.3.5. Comparison to a publicly available gene name normalization
system
We did a cross-check for the chosen examples with a different
gene name recognition and normalization system. Due to its public
availability we did a search within the evexdb database [32] for the
genes 6822, 26002 and 6296. This database uses state of the art
gene mention recognition via BANNER [33] and gene name nor-
malization via GenNorm [34]. We found that essentially the same
false positive hits had been detected for those genes, as in our set-
ting. Actually none of the detected regulation events for 26002 and
6296 was a true positive hit, independent of the given conﬁdence,
when accessing the database in December 2013. For 6822, among 8
detected regulation events only one contained a correct hit for the
sulfotransferase, while the others were actually describing events
for the hormone DHEAS. These results conﬁrm that the examples
identiﬁed in this study are realistic problems occurring in state
of the art gene name normalization that can be addressed by our
approach.4. Conclusions
We could show that KNIME and its recently added text process-
ing capabilities can be used to drastically reduce the number of
false positive hits for gene name normalization after possible hits
had been narrowed down to a smaller set of genes. The presented
workﬂow should be particularly helpful for usually problematic
gene names causing many false positive hits due to ambiguous
acronyms. Even if the secondary classiﬁcation step fails, the initial
processing step comprising acronym expansion and dictionary
matching, can help to reduce the size of the remaining dataset that
has to be curated manually. Thus, this approach can be a time saver
in manual curation tasks or might even reveal interesting
information that might have been ignored otherwise due to being
obfuscated in a huge number of false positive hits, as shown for
the example SAH. This study also demonstrates that it could be
helpful for the further development of algorithms for gene name
normalization to use current state of the art approaches in orderto identify common errors and setup solutions to speciﬁcally deal
with these issues. Our automated curation approach could also
be helpful in the easier creation of such novel training data sets.
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